ROCHESTER, N.Y. — Some pharmaceutical companies are pushing to make the COVID-19 vaccine eligible for kids between ages 12 and 15.

“I think vaccinating children will give parents an added level of security to kind of start moving back towards normal,” said Dr. Jennifer Nayak, associate professor of pediatrics at the University of Rochester Medical Center (URMC).

Two physicians at the University of Rochester Medical Center are backing the data released, as Pfizer looks for the FDA to grant emergency use authorization for children.

“We don’t want them to skip steps, nobody does, we want them to go through the process, the FDA to go through the process. And we’re hopeful, optimistic that it will be approved for children 12 and up,” said Dr. Mary Caserta, a professor of pediatrics and physician at URMC. “I think all of pediatrics agrees this is a good thing to bring to vaccines into children, because we need to protect children as well as adults from COVID and we need to protect all of our communities.”

One parent Spectrum News talked to is still waiting things out and seeing how the vaccine responds to different people. Blaster Riggins added that he’s not against the vaccine, but is a little hesitant about it.

“I would definitely take it first to see how my body reacts to it and see what the side effects are with me, then advise him,” said Riggins.

In addition to taking the vaccine first, the father said he would talk to a doctor first about his son getting the vaccine. As of now, the biggest concern for Riggings are the complications some people are having from the vaccine.

“The general concerns are the different complications that people are having, and that’s really the only concern for me. If there were zero complications, then I’d be like ‘oh, let’s get it today,’” said Riggins.

Physicians at URMC are recommending parents to talk their child’s pediatrician about the vaccine when the time comes.

“Every parent should be thinking about this, should be talking to their doctor about what they should do and asking the question about what they can do to protect their children,” Nayak said.

Pfizer says preliminary results shows their vaccine has a 100% efficacy against the virus for children between the age of 12 and 15.